Investors, Don’t Forget There’s Life After 60

The aging of the global population is having a profound impact on consumers, companies and investors.

There is a massive, irreversible transformation under way in the U.S. and across the globe. It is poorly understood and often overlooked. Halfway through the second decade of our 21st century, we are failing to grasp the implications of population aging.

Life spans that have for the history of humankind been unimaginable are today the norm. Low birth rates that for centuries would have spelled the end of a civilization are now common. By midcentury, there will be more of us over 60 than under 14. A half century ago this demographic state of affairs would have been inconceivable.

The implications are profound. At personal and familial levels, each of us must ask a new set of questions about how to achieve financial security when we may live to celebrate our 100th birthday. At the societal level we confront a retirement crisis prompted by our stubborn refusal to recognize that 20th-century schemes don’t fit 21st-century lives. Retirement at 60 or 65 will make sense for very few among us when we must plan to live past 90.

The questions are equally complex for investors. First, there is the business opportunity. There will soon be 1 billion of us over 60, and we hold the lion’s share of the world’s disposable income. With longer lives – and better health in older age – a new consumer base emerges. These consumers want and need products and services that are different from when they were younger – and different, too, from what their parents wanted at their age.

As hundreds of millions of us live into our 80s and beyond, our tastes literally are changing, along with our body shapes, living conditions and leisure preferences. Which businesses are preparing to capitalize on this seismic opportunity?

Sure, health companies understand the diseases of aging; financial institutions are starting to get it too. But are there food companies creating products specifically for 75-year-old taste buds? Which travel company is accommodating the interests of and marketing to older travelers? Who is creating houses, appliances, furniture and other home goods for octogenarians? Which film companies are making movies that appeal to older viewers? Is there a technology company building the wearables market to assist the deteriorating hearing, vision and skin? What innovator is out there marrying fashion and need – dresses, shoes or bathing suits for the over-70 crowd?

The smart investor will look beyond the “baby boomer bulge” headlines and recognize that aging is not a trend but a revolutionary transformation. All over the world socioeconomic forces – urbanization, education, women’s rights, health care innovation and more – are intersecting to create real, enduring change. The smart investor will understand this is now a part of consumer demand writ large.

For investors the aging megatrend introduces a new set of metrics by which to measure the potential success of a company.

  • Is a culture of “age-friendliness” being cultivated within the organization? Will research, business development, strategy and marketing teams be recognized and rewarded for creative approaches to products and services that will sell to over-60 consumers?
  • Has population aging also shaped hiring and retention strategies? Paying retirement at 65 worked 50 years ago because there were so few who lived much past that age and most people could not or did not want to work as they got older. Now, it is a recipe for failure.
  • Is the company investing in research or marketing that will attend to an older demographic? Does it have a growth strategy based on aging?
  • Which companies are reshaping their benefits packages to attract and retain talent? And does this include benefits a 55-year-old might want as well as those for the 32-year-old who will be around for 60 or more years?
  • Does the organization have a strategic approach to align its future with the social, political and institutional changes that will occur externally as a result of the phenomenon?

In 2010, S&P, now a division of McGraw Hill Financial, broke important ground in its Global Aging report, asserting that “no other force is likely to shape the future of national economic health, public finances and policymaking as the irreversible rate at which the world’s population is aging.” Six years later we now understand that aging is equally a market force.

If a business wishes to be competitive and win in the 21st century, it will build a strategy to capture the opportunities brought by population aging. If an investor wants to succeed, he or she will look to these leaders as among the most prescient and worthy of investment.

Source: Institutional Investor

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Brazil Must Fight Antibiotic Resistance

The threat posed by antimicrobial resistance is urgent and spares no country - including Brazil. According to The Lancet, 63 deaths per 100,000 are associated with AMR in Brazil and Paraguay, a rate that exceeds the average for Latin America and the Caribbean. AMR-associated deaths in Brazil are second only to cardiovascular diseases and cancers.

We Missed 100 Million Adult Vaccines – Here’s How We Get Back on Track

Like other pandemics throughout human history, COVID-19 has caused profound changes that are still rippling through our societies, even as people are understandably eager to move on. In fact, these impacts are all the more dangerous when they are largely ignored or effectively invisible. The decline in adult vaccination may be one of the most significant, as a new report finds that ~100 million doses were missed in 2021 and 2022 alone – reversing global progress towards widespread adult immunisation as a new standard of care in a world of more old than young.

New Analysis Shows Lost Ground on Adult Immunisation During the Pandemic with 100 Million Doses Potentially Missed

New data shared today by GSK, in collaboration with the IQVIA Institute for Human Data Science and the Global Coalition on Aging (GCOA), estimate approximately 100 million fewer doses of some adult vaccines (excluding Covid-19 vaccines) were administered in 2021 and 2022 than anticipated, based on the global vaccination adoption trends observed from 2013 to 2020, compounding already low adoption rates pre-pandemic.

Going Beyond Applause: The Potential of Caregiving to Unlock Job Opportunities of the Future

Early in the COVID-19 pandemic, the role of caregivers – staff and family who provide care for older and dependent people to carry out activities such as eating or moving - catapulted to the front of our collective conscience. The daily applause for front-line care workers showed a high level of recognition for their incredible work and provided insight into how our health systems must change as our society ages. We need to continue to recognise caregivers as essential to our ageing society.

High-Level Forum on the Silver Economy 2023

Join us for the High-Level Forum on the Silver Economy 2023. Now in its fourth year, the Silver Economy Forum 2023, December 6 and 7, will explore aging at every stage of life, looking at the growing global Silver Economy through a multigenerational lens. Linking to the goals and aspirations of the UN Decade of Healthy Ageing, SEF 2023 will highlight key themes at the intersection of aging at every age, and the Silver Economy.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.